Literature DB >> 1058037

Agglutination of peripheral blood lymphocytes from cancer patients and not from healthy controls, with the F2A1 histone fraction.

D Sabolović, N Sabolović, A Moutte, S Leibovici, B Sauvezie, P Chollet, R Plagne.   

Abstract

A simple, rapid histone agglutination test (HAT) is described. It consists of incubation in microplates or in microtubes of blood lymphocytes isolated from cancer patients and patients with non-malignant diseases with microquantities of histone fraction F2A1. Positive reaction is shown by massive agglutination of lymphocytes of the patients tested (126 subjects): this test was positive in 76% of cases. All controls (59 subjects) were negative.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1058037      PMCID: PMC2024777          DOI: 10.1038/bjc.1975.130

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Electrophoretic mobility, rosette formation and surface immunoglobulins of gradient fractionated human blood lymphocytes.

Authors:  N Sabolović; D Sabolović; F Dumont; G Siest
Journal:  Biomedicine       Date:  1974-02

2.  "Spontaneous" lymphocyte reactivity in the presence of virus infection.

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1972-04-29       Impact factor: 79.321

3.  Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

Review 4.  Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity.

Authors:  A C Allison; A M Denman; R D Barnes
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

5.  The chemical nature of cancer basic protein.

Authors:  J P Dickinson; E A Caspary
Journal:  Br J Cancer Suppl       Date:  1973-08

6.  Isolation of an "antigen" from malignant tumours.

Authors:  P R Carnegie; E A Caspary; E J Field
Journal:  Br J Cancer Suppl       Date:  1973-08

7.  Lymphocyte sensitisation: an in-vitro test for cancer?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

8.  Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.

Authors:  E J Field; E A Caspary; K S Smith
Journal:  Br J Cancer Suppl       Date:  1973-08

9.  Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?

Authors:  E A Caspary; E J Field
Journal:  Br Med J       Date:  1971-06-12

10.  Human peripheral lymphocytes and cancer. In vitro studies on the basic protein, histone F2A1 fraction.

Authors: 
Journal:  Br J Cancer       Date:  1974-09       Impact factor: 7.640

  10 in total
  6 in total

1.  Usefulness of the PAL test in the diagnosis of lung cancer.

Authors:  E Kłosińska-Kita; E Wiatr; B Rykiel; E Rowińska; W Roszkowski
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

2.  Isolation of histone proteins from rat normal and tumour blood plasma.

Authors:  D Daskalov; I Gavasova
Journal:  Experientia       Date:  1978-04-15

3.  PAL-test for malignant disease.

Authors:  H W Bauer; W Ax
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-08-24

4.  The PAL test for malignant disease in man.

Authors:  W A Schottler; H W Bauer
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

5.  Detection of sensitized human blood lymphocytes by agglutination with basic peptides: a possible test for malignant disease.

Authors:  H W Bauer; W Ax
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

6.  Responses of cancer patients in the MEM test: not just a function of charge on basic proteins.

Authors:  A Shaw; G Ettin; T A McPherson
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.